The role of tumor necrosis factors (TNF-alpha) in patients with chronic obstructive lung disease in combination with stomach and duodenum ulcer diseases
Solomatin, V.P.; Bredikhina, N.A.
Eksperimental'naia i Klinicheskaia Gastroenterologiia 4: 25-28
2007
ISSN/ISBN: 1682-8658 PMID: 18411442 Document Number: 614253
Document emailed within 1 workday
Related Documents
2011: Leptin and activity of tumor necrosis factor alpha relations with parameters of the trophologic status and digestion in patients with chronic obstructive pulmonary disease Terapevticheskii Arkhiv 83(3): 11-17Chu, C.-J.; Lu, R.-H.; Wang, S.-S.; Chang, F.-Y.; Wu, S.-L.; Lu, C.-L.; Chun, B.-C.; Chang, C.-Y.; Wu, M.-Y.; Lee, S.-D. 2007: Risk factors associated with non-alcoholic fatty liver disease in Chinese patients and the role of tumor necrosis factor-alpha Hepato-Gastroenterology 54(79): 2099-2102
Stepanishcheva, L.A.; Sarsenbaeva, A.S.; Fattakhova, N.V. 2013: Influence of the comorbidity diseases and risk factors on development of the combined peptic ulcer of the stomach and the duodenum Eksperimental'naia i Klinicheskaia Gastroenterologiia 8: 34-40
Goel, A.; Suri, J.C.; Aggarwal, K. 1992: Role of corticosteroids in the management of chronic obstructive lung disease: factors predicting response Indian Journal of Chest Diseases and Allied Sciences 34(1): 11-17
Zabel, P.; Schlaak, M. 1993: Tumor necrosis factor alpha in lung diseases Pneumologie 47(2): 49-52
Yang, S.C.; Owen-Schaub, L.; Mendiguren-Rodriguez, A.; Grimm, E.A.; Hong, W.K.; Roth, J.A. 1990: Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha Journal of Thoracic and Cardiovascular Surgery 99(1): 8
Rubin, A.E.; Bruderman, I. 1977: Alpha 1-Antitrypsin in the serum and chronic obstructive lung diseases and liver diseases Harefuah 92(3): 132-133
Zawada, K.; Bratek, A.; Krysta, K. 2015: Psychological distress and social factors in patients with asthma and chronic obstructive lung disease Psychiatria Danubina 27(Suppl 1): S462-S464
Kozlova, L.I.; Buzunov, R.V.; Chuchalin, A.G. 2001: Chronic obstructive lung diseases in patients with ischemic heart disease: a 15-year study Terapevticheskii Arkhiv 73(3): 27-32
Dubaybo, B.A. 1998: Role of tumor necrosis factor-alpha in regulating fibrotic lung repair Research Communications in Molecular Pathology and Pharmacology 101(1): 69-83
Korolev, M.P.; Bykov, A.M. 2000: Determination of indications for preoperative blood transfusion in patients with chronic ulcer of the stomach and duodenum complicated by hemorrhage Vestnik Khirurgii Imeni I. I. Grekova 159(4): 74-75
Villani, F.; Dell'Oca, I.; De Maria, P.; Viola, G.; Di Russo, A.; Viviani, S.; Bonfante, V. 1999: Lung function and serum concentration of tumor necrosis factor-alpha, interleukin-6 and fibronectin in patients treated with ABVD chemotherapy followed by radiotherapy for mediastinal Hodgkin's disease Anticancer Research 19(5c): 4475-4479
Egido, J.; Gómez-Chiarri, M.; Ortíz, A.; Bustos, C.; Alonso, J.; Gómez-Guerrero, C.; Gómez-Garre, D.; López-Armada, M.J.; Plaza, J.; Gonzalez, E. 1993: Role of tumor necrosis factor-alpha in the pathogenesis of glomerular diseases Kidney International. Suppl 39: S59-S64
Kaneko, H.; Yamada, H.; Mizuno, S.; Udagawa, T.; Kazumi, Y.; Sekikawa, K.; Sugawara, I. 1999: Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice Laboratory Investigation; a Journal of Technical Methods and Pathology 79(4): 379-386
Strieter, R.M.; Kunkel, S.L.; Bone, R.C. 1993: Role of tumor necrosis factor-alpha in disease states and inflammation Critical Care Medicine 21(10 Suppl): S447-S463
Lockhart, A. 1979: Exercise limiting factors in chronic obstructive lung diseases Bulletin Europeen de Physiopathologie Respiratoire 15(2): 305-320
Frolov, V.M.; Iakovlev, T.N. 1970: Functional status of the muscular system in patients with chronic diseases of the stomach and duodenum before and after administration of ascorbic acid Terapevticheskii Arkhiv 42(12): 48-52
Grebska, E.; Radwan, L. 1979: Changes in lung capacity under the influence of bronchodilators in patients with chronic obstructive lung diseases Pneumonologia Polska 47(11): 775-780
Antoni, C.; Kalden, J.R. 1999: Combination therapy of the chimeric monoclonal anti-tumor necrosis factor alpha antibody (infliximab) with methotrexate in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 17(6 Suppl 18: S73-S77
Gad, H.I. 2013: The potential role of anti tumor necrosis factor-alpha antibodies on some renal functions and vasoregulatory factors in preeclamptic pregnant Wistar rats Saudi Medical Journal 34(5): 490-496